These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36896475)

  • 1. Thermosusceptible Nitric-Oxide-Releasing Nitrogel for Strengthening Antitumor Immune Responses with Tumor Collagen Diminution and Deep Tissue Delivery during NIR Laser-Assisted Photoimmunotherapy.
    Mohapatra A; Mondal J; Sathiyamoorthy P; Mohanty A; Revuri V; Rajendrakumar SK; Lee YK; Park IK
    ACS Appl Mater Interfaces; 2023 Mar; ():. PubMed ID: 36896475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cu
    He J; Song R; Xiao F; Wang M; Wen L
    Int J Nanomedicine; 2023; 18():3021-3033. PubMed ID: 37312933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photosensitizer Micelles Together with IDO Inhibitor Enhance Cancer Photothermal Therapy and Immunotherapy.
    Peng J; Xiao Y; Li W; Yang Q; Tan L; Jia Y; Qu Y; Qian Z
    Adv Sci (Weinh); 2018 May; 5(5):1700891. PubMed ID: 29876215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Targeted Gene Silencing IDO Synergizes PTT-Induced Apoptosis and Enhances Anti-tumor Immunity.
    Zhang Y; Feng Y; Huang Y; Wang Y; Qiu L; Liu Y; Peng S; Li R; Kuang N; Shi Q; Shi Y; Chen Y; Joshi R; Wang Z; Yuan K; Min W
    Front Immunol; 2020; 11():968. PubMed ID: 32582152
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultra-small Janus nanoparticle-induced activation of ferroptosis for synergistic tumor immunotherapy.
    Wang J; Wang Z; Li L; Wang M; Chang J; Gao M; Wang D; Li C
    Acta Biomater; 2024 Jun; 181():362-374. PubMed ID: 38663684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fighting Immune Cold and Reprogramming Immunosuppressive Tumor Microenvironment with Red Blood Cell Membrane-Camouflaged Nanobullets.
    Yang Z; Gao D; Guo X; Jin L; Zheng J; Wang Y; Chen S; Zheng X; Zeng L; Guo M; Zhang X; Tian Z
    ACS Nano; 2020 Dec; 14(12):17442-17457. PubMed ID: 33166111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoscale Reduced Graphene Oxide-Mediated Photothermal Therapy Together with IDO Inhibition and PD-L1 Blockade Synergistically Promote Antitumor Immunity.
    Yan M; Liu Y; Zhu X; Wang X; Liu L; Sun H; Wang C; Kong D; Ma G
    ACS Appl Mater Interfaces; 2019 Jan; 11(2):1876-1885. PubMed ID: 30582788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-Sensitive Gold-Nanocubes Platform with Synergistic Immunotherapy for Inducing Immune Cycle Using NIR-Mediated PTT/NO/IDO.
    Tsao HY; Cheng HW; Kuo CC; Chen SY
    Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogrammed IDO-Induced Immunosuppressive Microenvironment Synergizes with Immunogenic Magnetothermodynamics for Improved Cancer Therapy.
    Wang X; Yan B; Li H; Yuan J; Guo J; Wang S; Dai P; Liu X
    ACS Appl Mater Interfaces; 2024 Jun; 16(24):30671-30684. PubMed ID: 38843203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light-responsive hyaluronic acid nanomicelles co-loaded with an IDO inhibitor focus targeted photoimmunotherapy against "immune cold" cancer.
    Wu C; Xu J; Xie Z; Huang H; Li N; Wei X; Li T; Yang H; Li S; Qin X; Liu Y
    Biomater Sci; 2021 Nov; 9(23):8019-8031. PubMed ID: 34718362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ photothermal nano-vaccine based on tumor cell membrane-coated black phosphorus-Au for photo-immunotherapy of metastatic breast tumors.
    Huang D; Wu T; Lan S; Liu C; Guo Z; Zhang W
    Biomaterials; 2022 Oct; 289():121808. PubMed ID: 36137415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
    Liu D; Chen B; Mo Y; Wang Z; Qi T; Zhang Q; Wang Y
    Nano Lett; 2019 Oct; 19(10):6964-6976. PubMed ID: 31518149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation.
    Lemos H; Mohamed E; Huang L; Ou R; Pacholczyk G; Arbab AS; Munn D; Mellor AL
    Cancer Res; 2016 Apr; 76(8):2076-81. PubMed ID: 26964621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STING agonist and IDO inhibitor combination therapy inhibits tumor progression in murine models of colorectal cancer.
    Shi J; Liu C; Luo S; Cao T; Lin B; Zhou M; Zhang X; Wang S; Zheng T; Li X
    Cell Immunol; 2021 Aug; 366():104384. PubMed ID: 34182334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular matrix-degrading STING nanoagonists for mild NIR-II photothermal-augmented chemodynamic-immunotherapy.
    Zhan M; Yu X; Zhao W; Peng Y; Peng S; Li J; Lu L
    J Nanobiotechnology; 2022 Jan; 20(1):23. PubMed ID: 34991618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.
    Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q
    Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photothermal-Enhanced Dual Inhibition of Lactate/Kynurenine Metabolism for Promoting Tumor Immunotherapy.
    Xie Y; Wang M; Qiao L; Qian Y; Xu W; Sun Q; Luo S; Li C
    Small Methods; 2024 Mar; 8(3):e2300945. PubMed ID: 37906051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Activatable Dual Polymer Nanosystem for Photoimmunotherapy and Metabolic Modulation of Deep-Seated Tumors.
    Liu G; Li J; Wang X; Ren H; Zhang Y
    Adv Healthc Mater; 2024 Apr; 13(9):e2303305. PubMed ID: 38277491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of a STING Agonist and Photothermal Therapy Using Chitosan Hydrogels for Cancer Immunotherapy.
    Chen C; Hu M; Cao Y; Zhu B; Chen J; Li Y; Shao J; Zhou S; Shan P; Zheng C; Li Z; Li Z
    Biomacromolecules; 2023 Jun; 24(6):2790-2803. PubMed ID: 37125731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway.
    Lu J; Liu X; Liao YP; Wang X; Ahmed A; Jiang W; Ji Y; Meng H; Nel AE
    ACS Nano; 2018 Nov; 12(11):11041-11061. PubMed ID: 30481959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.